Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI? CON
Kidney360
.
2023 Dec 1;4(12):1667-1669.
doi: 10.34067/KID.0000000000000188.
Epub 2023 Jun 9.
Author
Steven G Coca
1
Affiliation
1
Barbara T. Murphy Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
PMID:
37291706
PMCID:
PMC10758505
DOI:
10.34067/KID.0000000000000188
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Acute Kidney Injury* / diagnosis
Biomarkers
Humans
Prognosis
Substances
Biomarkers
Grants and funding
U01 DK082185/DK/NIDDK NIH HHS/United States
U01 DK106962/DK/NIDDK NIH HHS/United States
U01 DK133093/DK/NIDDK NIH HHS/United States
R01 DK126477/DK/NIDDK NIH HHS/United States
R01 DK127139/DK/NIDDK NIH HHS/United States
R01 DK129467/DK/NIDDK NIH HHS/United States